Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era

BACKGROUND: This study aimed to propose a new user-friendly, cost effective and robust risk model to facilitate risk stratification for diffuse large B-cell lymphoma (DLBCL) treated with frontline R-CHOP regimens. METHODS: Data on 998 patients with de novo DLBCL diagnosed between Jan 1st, 2005 and D...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haizhu, Zhong, Qiaofeng, Zhou, Yu, Qin, Yan, Yang, Jianliang, Liu, Peng, He, Xiaohui, Zhou, Shengyu, Zhang, Changgong, Gui, Lin, Yang, Sheng, Zhou, Liqiang, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137167/
https://www.ncbi.nlm.nih.gov/pubmed/35624433
http://dx.doi.org/10.1186/s12885-022-09693-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137167/
https://www.ncbi.nlm.nih.gov/pubmed/35624433
http://dx.doi.org/10.1186/s12885-022-09693-z

Ejemplares similares